Emerald Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-500,974
| Closed | -$12M | – | 357 |
|
|
2019
Q4 | $12M | Sell |
500,974
-490
| -0.1% | -$11.7K | 0.51% | 86 |
|
|
2019
Q3 | $13.4M | Sell |
501,464
-35,406
| -7% | -$950K | 0.63% | 60 |
|
|
2019
Q2 | $14.6M | Buy |
536,870
+131,750
| +33% | +$3.57M | 0.59% | 75 |
|
|
2019
Q1 | $14.1M | Buy |
+405,120
| New | +$14.1M | 0.57% | 67 |
|
|
2018
Q1 | – | Sell |
-540,661
| Closed | -$26.3M | – | 275 |
|
|
2017
Q4 | $26.3M | Buy |
540,661
+86,740
| +19% | +$4.22M | 1.01% | 32 |
|
|
2017
Q3 | $24.5M | Buy |
453,921
+9,703
| +2% | +$524K | 1% | 35 |
|
|
2017
Q2 | $25M | Buy |
444,218
+152,225
| +52% | +$8.55M | 1.04% | 42 |
|
|
2017
Q1 | $11.4M | Sell |
291,993
-394,058
| -57% | -$15.4M | 0.47% | 86 |
|
|
2016
Q4 | $15.4M | Sell |
686,051
-57,508
| -8% | -$1.29M | 0.66% | 65 |
|
|
2016
Q3 | $16.9M | Buy |
743,559
+103,115
| +16% | +$2.34M | 0.75% | 39 |
|
|
2016
Q2 | $15.1M | Buy |
640,444
+301,550
| +89% | +$7.12M | 0.73% | 43 |
|
|
2016
Q1 | $6.91M | Buy |
338,894
+123,350
| +57% | +$2.52M | 0.34% | 101 |
|
|
2015
Q4 | $11.1M | Buy |
215,544
+25,156
| +13% | +$1.29M | 0.52% | 69 |
|
|
2015
Q3 | $8.11M | Sell |
190,388
-241,778
| -56% | -$10.3M | 0.42% | 78 |
|
|
2015
Q2 | $19.7M | Sell |
432,166
-734
| -0.2% | -$33.4K | 0.94% | 28 |
|
|
2015
Q1 | $15.7M | Buy |
432,900
+40,151
| +10% | +$1.45M | 0.79% | 33 |
|
|
2014
Q4 | $11.1M | Buy |
392,749
+75,432
| +24% | +$2.14M | 0.59% | 54 |
|
|
2014
Q3 | $8.02M | Buy |
317,317
+27,647
| +10% | +$699K | 0.48% | 72 |
|
|
2014
Q2 | $8.45M | Sell |
289,670
-1,531
| -0.5% | -$44.7K | 0.48% | 73 |
|
|
2014
Q1 | $7.54M | Buy |
291,201
+31,446
| +12% | +$814K | 0.42% | 82 |
|
|
2013
Q4 | $6.69M | Sell |
259,755
-11,820
| -4% | -$304K | 0.36% | 95 |
|
|
2013
Q3 | $7.27M | Buy |
271,575
+4,765
| +2% | +$127K | 0.41% | 80 |
|
|
2013
Q2 | $6.56M | Buy |
+266,810
| New | +$6.56M | 0.4% | 82 |
|